These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16177439)

  • 1. Pathogenesis of contrast-induced nephropathy.
    Heinrich M; Uder M
    AJR Am J Roentgenol; 2005 Oct; 185(4):1079; author reply 1079. PubMed ID: 16177439
    [No Abstract]   [Full Text] [Related]  

  • 2. Using estimated GFR values to identify patients at risk from iodinated contrast induced nephropathy.
    Adair W; Harris K; Entwisle J
    Clin Radiol; 2006 Aug; 61(8):714-5. PubMed ID: 16843758
    [No Abstract]   [Full Text] [Related]  

  • 3. Water for contrast-induced nephropathy? A thirst for knowledge.
    Pate GE; Webb JG
    J Invasive Cardiol; 2003 Dec; 15(12):703-5. PubMed ID: 14660822
    [No Abstract]   [Full Text] [Related]  

  • 4. Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines.
    Thomsen HS; Morcos SK
    Br J Radiol; 2003 Aug; 76(908):513-8. PubMed ID: 12893691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: Using estimated GFR values to identify patients at risk from iodinated contrast-induced nephropathy.
    Dyer JD; Dyer JB
    Clin Radiol; 2007 Mar; 62(3):285; author reply 285. PubMed ID: 17293225
    [No Abstract]   [Full Text] [Related]  

  • 6. [Symposium "Nephropathy Caused by Contrast Media" (in the program of the XLI congress of the European Kidney Association. 15-18 May, 2004, Lisbon)].
    Shimanovskiĭ NL; Napolov NK
    Urologiia; 2005; (2):68-70. PubMed ID: 15989034
    [No Abstract]   [Full Text] [Related]  

  • 7. [Contrast medica nephropathy. Better understanding of risk markers and follow up needed].
    Sterner G; Hellström M; Lagerqvist B; Aspelin P; Nyman U
    Lakartidningen; 2009 Jun 24-Jul 7; 106(26-27):1737-42. PubMed ID: 19731735
    [No Abstract]   [Full Text] [Related]  

  • 8. Contrast-induced nephropathy: nursing implications.
    Isaac S
    Crit Care Nurse; 2012 Jun; 32(3):41-8. PubMed ID: 22661157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of theophylline in prevention of radiocontrast media-induced nephropathy.
    Malhis M; Al-Bitar S; Al-Deen Zaiat K
    Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):276-83. PubMed ID: 20228513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-induced nephropathy: does it really exist?
    Buckenham TM
    N Z Med J; 2009 Jul; 122(1299):5-6. PubMed ID: 19684640
    [No Abstract]   [Full Text] [Related]  

  • 11. N-acetylcysteine and contrast-induced nephropathy.
    Ritz E
    N Engl J Med; 2006 Oct; 355(14):1499; author reply 1499-500. PubMed ID: 17024738
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures.
    Schweiger MJ; Chambers CE; Davidson CJ; Blankenship J; Bhalla NP; Block PC; Dervan JP; Gasperetti C; Gerber L; Kleiman NS; Krone RJ; Phillips WJ; Siegel RM; Uretsky BF; Laskey WK
    Catheter Cardiovasc Interv; 2007 Jan; 69(1):135-40. PubMed ID: 17139671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrotoxicity from contrast media: attenuation with theophylline.
    Morcos SK; Brown PW
    Radiology; 1995 Nov; 197(2):546-7; dicussion 248. PubMed ID: 7480713
    [No Abstract]   [Full Text] [Related]  

  • 14. The editor's roundtable: contrast agents and risk for contrast-induced nephropathy.
    Friedewald VE; Goldfarb S; Laskey WK; Vetrovec GW; Roberts WC
    Am J Cardiol; 2011 Jun; 107(12):1848-55. PubMed ID: 21640219
    [No Abstract]   [Full Text] [Related]  

  • 15. Contrast safety in the cancer patient: preventing contrast-induced nephropathy.
    Heiken JP
    Cancer Imaging; 2008 Oct; 8 Spec No A(Spec Iss A):S124-7. PubMed ID: 18852085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can contrast-induced nephropathy after percutaneous coronary intervention be accurately predicted with a risk score?
    Marenzi G
    Nat Clin Pract Cardiovasc Med; 2005 Feb; 2(2):80-1. PubMed ID: 16265376
    [No Abstract]   [Full Text] [Related]  

  • 17. Contrast-induced nephropathy risk assessment in real world practice.
    Rabbani AB; Nallamothu BK
    Am J Med; 2011 Dec; 124(12):1127-8. PubMed ID: 22114825
    [No Abstract]   [Full Text] [Related]  

  • 18. Contrast-induced nephropathy.
    Gleeson TG; Bulugahapitiya S
    AJR Am J Roentgenol; 2004 Dec; 183(6):1673-89. PubMed ID: 15547209
    [No Abstract]   [Full Text] [Related]  

  • 19. Adenosine, renal function and kidney viability.
    Gelman S; Sadovnikoff N
    Kidney Int; 1999 May; 55(5):2076-7. PubMed ID: 10234670
    [No Abstract]   [Full Text] [Related]  

  • 20. Contrast agent-induced nephropathy: a simple way to identify patients with preexisting renal insufficiency.
    Ashley JB; Millward SF
    AJR Am J Roentgenol; 2003 Aug; 181(2):451-4. PubMed ID: 12876025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.